Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Ashley

Showing results (1-10 of 210) with videos related to

Pageof 21
Sort By:
Clinical Medicine (London, England)|February 3, 2017
Post-malaria neurological syndromesElizabeth A Ashley
The Lancet. Infectious Diseases|May 3, 2025
Missing the target for antibiotic accessElizabeth A Ashley, Vilada Chansamouth
The Lancet. Infectious Diseases|October 29, 2019
Standardising the reporting of microbiology and antimicrobial susceptibility dataPaul Turner, Elizabeth A Ashley
Lancet (London, England)|December 6, 2020
Seasonal malaria chemoprevention: closing the know-do gapElizabeth A Ashley, Adoke Yeka
The Lancet. Infectious Diseases|April 11, 2020
Plasmodium falciparum ATP4 inhibitors to treat malaria: worthy successors to artemisinin?Elizabeth A Ashley, Aung Pyae Phyo
Current Opinion in Infectious Diseases|November 1, 2005
Artemisinin-based combinationsElizabeth A Ashley, Nicholas J White
The Lancet. Child & Adolescent Health|September 18, 2020
Treatment and prevention of malaria in childrenElizabeth A Ashley, Jeanne Rini Poespoprodjo
Drugs|May 27, 2018
Drugs in Development for MalariaElizabeth A Ashley, Aung Pyae Phyo
Malaria Journal|December 18, 2014
The duration of Plasmodium falciparum infectionsElizabeth A Ashley, Nicholas J White
Annals of Neurology|March 28, 2006
Toxic brainstem encephalopathy after artemisinin treatment for breast cancerNicholas J White, Elizabeth A Ashley, Francois Nosten
Pageof 21

Showing results (1-10 of 210) with videos related to

Sort By:
Pageof 21
Clinical Medicine (London, England)|February 3, 2017
Post-malaria neurological syndromesElizabeth A Ashley
The Lancet. Infectious Diseases|May 3, 2025
Missing the target for antibiotic accessElizabeth A Ashley, Vilada Chansamouth
The Lancet. Infectious Diseases|October 29, 2019
Standardising the reporting of microbiology and antimicrobial susceptibility dataPaul Turner, Elizabeth A Ashley
Lancet (London, England)|December 6, 2020
Seasonal malaria chemoprevention: closing the know-do gapElizabeth A Ashley, Adoke Yeka
The Lancet. Infectious Diseases|April 11, 2020
Plasmodium falciparum ATP4 inhibitors to treat malaria: worthy successors to artemisinin?Elizabeth A Ashley, Aung Pyae Phyo
Current Opinion in Infectious Diseases|November 1, 2005
Artemisinin-based combinationsElizabeth A Ashley, Nicholas J White
The Lancet. Child & Adolescent Health|September 18, 2020
Treatment and prevention of malaria in childrenElizabeth A Ashley, Jeanne Rini Poespoprodjo
Drugs|May 27, 2018
Drugs in Development for MalariaElizabeth A Ashley, Aung Pyae Phyo
Malaria Journal|December 18, 2014
The duration of Plasmodium falciparum infectionsElizabeth A Ashley, Nicholas J White
Annals of Neurology|March 28, 2006
Toxic brainstem encephalopathy after artemisinin treatment for breast cancerNicholas J White, Elizabeth A Ashley, Francois Nosten
Pageof 21